Cancer centers see a bigger role for telemedicine in clinical trials

by on

Oncologists say there is a permanent place for telemedicine in cancer clinical trials post-COVID because of the potential to improve access but there are caveats to consider.

Oncologists say there is a permanent place for telemedicine in cancer clinical trials post-COVID because of the potential to improve access but there are caveats to consider.

VA:F [1.9.7_1111]
Rating: 0.0/10 (0 votes cast)
VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)

Leave a Comment

Previous post:

Next post: